Amalgamated Bank Catalyst Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 32,850 shares of CPRX stock, worth $720,072. This represents 0.01% of its overall portfolio holdings.

Number of Shares

32,850

Previous 34,256 4.1%

Holding current value

$720,072

Previous $531,000 22.98%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$15.19 - $21.35 $21,357 - $30,018	-1,406 Reduced 4.1%	32,850 $653,000
Q2 2024 Aug 12, 2024	SELL	$14.68 - $16.92 $15,971 - $18,408	-1,088 Reduced 3.08%	34,256 $531,000
Q1 2024 Apr 23, 2024	SELL	$13.18 - $17.11 $106,823 - $138,676	-8,105 Reduced 18.65%	35,344 $563,000
Q4 2023 Feb 06, 2024	SELL	$11.78 - $17.29 $10,354 - $15,197	-879 Reduced 1.98%	43,449 $730,000
Q2 2023 Aug 11, 2023	BUY	$11.5 - $18.08 $5,152 - $8,099	448 Added 1.02%	44,328 $595,000
Q1 2023 May 02, 2023	SELL	$14.34 - $21.05 $46,691 - $68,538	-3,256 Reduced 6.91%	43,880 $728,000
Q4 2022 Feb 10, 2023	BUY	$12.25 - $19.5 $12,531 - $19,948	1,023 Added 2.22%	47,136 $877,000
Q3 2022 Nov 09, 2022	BUY	$7.06 - $15.52 $218,577 - $480,499	30,960 Added 204.32%	46,113 $592,000
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $21,574 - $29,677	3,463 Added 29.62%	15,153 $106,000
Q1 2022 Jun 30, 2022	SELL	$5.31 - $8.31 $5,060 - $7,919	-953 Reduced 7.54%	11,690 $97,000
Q4 2021 Feb 15, 2022	SELL	$5.21 - $7.45 $2,094 - $2,994	-402 Reduced 3.08%	12,643 $86,000
Q3 2021 Oct 29, 2021	SELL	$4.85 - $6.04 $2,876 - $3,581	-593 Reduced 4.35%	13,045 $69,000
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $6,276 - $8,851	-1,463 Reduced 9.69%	13,638 $78,000
Q4 2020 Feb 12, 2021	BUY	$2.97 - $3.83 $267 - $344	90 Added 0.6%	15,101 $50,000
Q3 2020 Oct 30, 2020	SELL	$2.97 - $5.08 $1,006 - $1,722	-339 Reduced 2.21%	15,011 $45,000
Q2 2020 Aug 10, 2020	SELL	$3.48 - $5.05 $6,100 - $8,852	-1,753 Reduced 10.25%	15,350 $71,000
Q1 2020 May 13, 2020	BUY	$2.61 - $5.21 $177 - $354	68 Added 0.4%	17,103 $66,000
Q3 2019 Nov 13, 2019	SELL	$3.89 - $7.43 $439 - $839	-113 Reduced 0.66%	17,035 $90,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $5,559 - $12,580	2,059 Added 13.65%	17,148 $66,000
Q1 2019 May 15, 2019	BUY	$2.11 - $5.33 $1,052 - $2,659	499 Added 3.42%	15,089 $77,000
Q4 2018 Feb 15, 2019	BUY	$1.92 - $3.62 $28,012 - $52,815	14,590 New	14,590 $28,000
Q3 2018 Nov 14, 2018	SELL	$2.81 - $3.78 $41,846 - $56,291	-14,892 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$2.26 - $3.84 $7,661 - $13,017	3,390 Added 29.47%	14,892 $46,000
Q1 2018 May 22, 2018	BUY	$2.39 - $4.01 $27,489 - $46,123	11,502 New	11,502 $27,000

Others Institutions Holding CPRX

# of Institutions

325

Shares Held

94.1M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.25B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Catalyst Pharmaceuticals, Inc. Transaction History